ImmunologybioRxiv
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia
A. ALLOUCH, L. VOISIN, Y. ZHANG…·j.-l. PERFETTINI
This study shows that overexpressing CDKN1A in macrophages enhances their ability to phagocytose leukemic cells, leading to pro-inflammatory reprogramming and improved survival in mouse models.
DOI 10.1038/s41467-022-34548-3